Skip to main content
Clinical Trials/NCT04976569
NCT04976569
Recruiting
Not Applicable

Neuromodulation of Sleep Architecture by STN-DBS in Parkinsonian Patients

Tsinghua University1 site in 1 country5 target enrollmentAugust 10, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Parkinson Disease
Sponsor
Tsinghua University
Enrollment
5
Locations
1
Primary Endpoint
ratio of slow wave sleep
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Sleep disorder is one of the most burdensome non-motor symptoms in Parkinsonian patients. Typical manifestations include RBD, decreased sleep efficiency, decreased slow wave sleep, daytime sleepiness, increased sleep latency and wakefulness during sleep. Subthalamic nucleus (STN) deep brain stimulation (DBS) has been reported to improve sleep dysfunction in several studies, mostly due to its improvement in motor dysfunction. However, there are limited research about specific STN-DBS stimulation pattern for sleep architecture regulation, and whether suboptimal parameter combinations for motor has potential benefits for sleep improvement has not been studied. Here we use different parameter combination in STN-DBS, especially by changing stimulation contact and frequency, to explore the specific stimulation pattern for normalizing sleep architecture and increasing slow wave sleep.

Detailed Description

Investigators will enroll at least 5 subjects for this study. First, subjects will be clinically evaluated by motor, cognitive and sleep scales; Subsequently, the treatment window of each contact using unipolar stimulation will be tested both in high frequency (such as 130Hz) and low frequency (such as 80Hz), and the parameters of stimulation were determined under the premise of no obvious discomfort and optimal motor control. Different stimulation pattern (such as ventral contact stimulation) will be performed during the N2 phase combined with PSG and LFP recording during the patients' sleep, and switch to baseline stimulation pattern at the N3/N1/REM phase. Repeat these steps until the patient wake up naturally. Finally, the patients will be evaluated for motor function. Pre-surgery and post-surgery images will be used for reconstructing VTA of specific parameter combination. Functional MRI (fMRI) will be carried out to verify the connectivity change under optimal parameter combinations.

Registry
clinicaltrials.gov
Start Date
August 10, 2021
End Date
December 10, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Luming Li

: Director of National Engineering Laboratory for Neuromodulation

Tsinghua University

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of Parkinson's disease: The diagnostic criteria for Parkinson's disease are the Clinical Diagnostic Criteria of UK PD Society Brain Bank Clinical Diagnostic Criteria or 2015 MDS Clinical Diagnostic Criteria for PD.All diagnoses of Parkinson's disease were made by three neurologists who were experienced in the field of movement disorders.
  • Bilateral STN-DBS has been implanted for more than 1 year, and stable drug therapy regimen and parameter program control regimen have been maintained for 6 weeks or more;
  • Patients with onset age of 50 years and above;
  • Do not use phenobarbital, chloral hydrate, benzodiazepines and non-benzodiazepines as sedatives and hypnotics at night.

Exclusion Criteria

  • Patients who underwent pallidotomy and other brain surgery;
  • Other patients with secondary Parkinson's syndrome and Parkinsonism-plus syndrome;
  • Patients with other central nervous system and peripheral nervous system diseases;
  • Patients complicated with severe medical system diseases, patients with unstable vital signs and unable to tolerate clinical evaluation;
  • Patients with severe mental illness;
  • Use phenobarbital, chloral hydrate, benzodiazepines and non-benzodiazepines as sedatives and hypnotics at night;
  • Patients who cannot complete informed consent due to cognitive and communication barriers, or refuse to sign informed consent.

Outcomes

Primary Outcomes

ratio of slow wave sleep

Time Frame: through study completion, an average of 1 year

The percentage of slow wave sleep

Sleep Efficiency

Time Frame: through study completion, an average of 1 year

The percentage of time a person sleeps, in relation to the amount of time a person spends in bed

ratio of rem sleep

Time Frame: through study completion, an average of 1 year

The percentage of rem sleep

Secondary Outcomes

  • Motor Function Evaluation(through study completion, an average of 1 year)

Study Sites (1)

Loading locations...

Similar Trials